Skip to main content
TipRanks
Go Ultimate75% OFF

Neurogene (NGNE) Financial Statements

652 Followers

Neurogene Financial Overview

Neurogene's market cap is currently $474.67M. The company's EPS TTM is $-5.57; its P/E ratio is -3.98; Neurogene is estimated to report earnings on March 30, 2027, and the estimated EPS forecast is $-1.21. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 925.00K$ 0.00$ 0.00$ 0.00
Gross Profit$ -3.19M$ -2.32M$ -3.26M$ -3.20M$ -42.26M
Operating Income$ -103.21M$ -82.61M$ -55.58M$ -56.52M$ -50.53M
EBITDA$ -87.25M$ -71.89M$ -33.01M$ -51.99M$ -49.57M
Net Income$ -90.35M$ -75.14M$ -36.32M$ -55.19M$ -50.52M
Balance Sheet
Cash & Short-Term Investments$ 269.01M$ 312.40M$ 197.16M$ 82.02M$ 70.54M
Total Assets$ 288.60M$ 335.73M$ 222.57M$ 109.27M$ 101.49M
Total Debt$ 9.89M$ 12.43M$ 16.25M$ 4.69M$ 6.43M
Net Debt$ -93.95M$ -124.16M$ -131.96M$ -77.33M$ -64.11M
Total Liabilities$ 23.72M$ 25.36M$ 36.55M$ 10.64M$ 193.36M
Stockholders' Equity$ 264.89M$ 310.38M$ 186.02M$ 98.63M$ -91.88M
Cash Flow
Free Cash Flow$ -78.36M$ -71.41M$ -51.74M$ -55.05M$ -64.77M
Operating Cash Flow$ -77.17M$ -70.60M$ -51.42M$ -52.82M$ -46.40M
Investing Cash Flow$ 14.00M$ -125.26M$ 25.64M$ -2.23M$ -18.37M
Financing Cash Flow$ 30.43M$ 184.07M$ 92.48M$ 66.53M$ 51.06M

Currency in USD

Neurogene Earnings and Revenue History

-100M-50M050M-9000 %-6000 %-3000 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Neurogene Liabilities to Assets

0120M240M360M0 %80 %160 %240 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Neurogene Cash Flow

-200M-100M0100M200M201720182019202020212022202320242025OperatingInvestingFinancing

Neurogene Forecast EPS vs Actual EPS

-1.6-1.4-1.2-1-0.8Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss